Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$16.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 31 most recent Form 4 transactions.
| 55,000 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 350 | — | — | — | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 47,746 | $63.61 | $3M | -32.7% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 65,104 | $63.12 | $4.1M | -30.9% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 57,500 | $26.88 | $1.5M | +37.5% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 55,000 | $15.46 | $850.3K | +55.8% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 350 | $17.96 | $6.3K | +0.4% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 39,650 | — | — | — | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 39,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 270 | $65.31 | $17.6K | -0.3% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 3,000 | $63.65 | $191K | -3.0% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 29,021 | $62.66 | $1.8M | -22.2% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 63,907 | $61.99 | $4M | -32.9% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 39,650 | $17.96 | $712.1K | +25.6% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 39,000 | $25.25 | $984.8K | +33.7% | Open the original filing on SEC.gov |
| May 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,763 | $43.95 | $121.4K | -2.3% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,250 | — | — | +3.7% | Open the original filing on SEC.gov |
| Apr 22 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 9,100 | $39.09 | $355.7K | -7.4% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 14,000 | — | — | +12.8% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 12,446 | $32.87 | $409.1K | -10.2% | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 53,570 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 20,090 | — | — | +19.8% | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 60,000 | $40.10 | $2.4M | -37.2% | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 60,000 | $20.61 | $1.2M | +59.2% | Open the original filing on SEC.gov |
| May 5, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 3,198 | $21.05 | $67.3K | -3.1% | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,920 | — | — | — | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,920 | — | — | +5.0% | Open the original filing on SEC.gov |